PAM
VRCA icon

Panagora Asset Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Panagora Asset Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16
Closed -$2K – 2932
2020
Q4 		$2K Hold
16
– – ﹤0.01% 2655
2020
Q3 		$1K Buy
+16
New +$1.31K ﹤0.01% 2666

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Panagora Asset Management's VRCA Position: Q1 2021 in Review

Panagora Asset Management sold out of Verrica Pharmaceuticals (VRCA) in Q1 2021, closing a stake of 16 shares — an estimated $2K sold.

Panagora Asset Management first reported a position in VRCA in Q3 2020 and held it in 2 quarters. The position peaked at $2K in Q4 2020. 51 funds tracked by Wall St. Rank hold VRCA as of Q1 2021.

  • Panagora Asset Management reported no remaining Verrica Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Panagora Asset Management sold 16 Verrica Pharmaceuticals shares in Q1 2021, an estimated $2K.
  • Panagora Asset Management first reported a position in Verrica Pharmaceuticals in Q3 2020 and held it in 2 quarters.
  • Panagora Asset Management's Verrica Pharmaceuticals position peaked at $2K in Q4 2020.
  • 51 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2021.

Based on Panagora Asset Management's 13F filing for Q1 2021, filed 12 May 2021.